Akeso says its closely watched drug improved patient survival in a lung cancer trial Chinese biotech’s therapy is positioned as a rival to Merck’s Keytruda

https://www.statnews.com/2025/08/26/akeso-says-its-closely-watched-drug-improved-patient-survival-in-a-lung-cancer-trial/